Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Antioxidants & Redox Signaling|August 21, 2012
Disulfide bond formation in the bacterial periplasm: major achievements and challenges aheadKatleen Denoncin, Jean-François ColletBiochimica Et Biophysica Acta|November 19, 2013
Folding mechanisms of periplasmic proteinsCamille Goemans, Katleen Denoncin, Jean-François ColletThe Journal of Biological Chemistry|July 10, 2010
The protein-disulfide isomerase DsbC cooperates with SurA and DsbA in the assembly of the essential β-barrel protein LptDKatleen Denoncin, Didier Vertommen, Eunok Paek, et al.Methods in Molecular Biology (Clifton, N.J.)|January 10, 2013
Protein disulfide bond formation in the periplasm: determination of the in vivo redox state of cysteine residuesKatleen Denoncin, Valérie Nicolaes, Seung-Hyun Cho, et al.Proteomics|May 17, 2012
Dissecting the Escherichia coli periplasmic chaperone network using differential proteomicsKatleen Denoncin, Jaclyn Schwalm, Didier Vertommen, et al.The Journal of Biological Chemistry|April 2, 2011
Crystal structure of the outer membrane protein RcsF, a new substrate for the periplasmic protein-disulfide isomerase DsbCPauline Leverrier, Jean-Paul Declercq, Katleen Denoncin, et al.Molecular Microbiology|July 20, 2012
Overexpression of the rhodanese PspE, a single cysteine-containing protein, restores disulphide bond formation to an Escherichia coli strain lacking DsbAShu-Sin Chng, Rachel J Dutton, Katleen Denoncin, et al.The Journal of Biological Chemistry|March 18, 2014
A new role for Escherichia coli DsbC protein in protection against oxidative stressKatleen Denoncin, Didier Vertommen, Isabelle S Arts, et al.Science (New York, N.Y.)|December 8, 2009
A periplasmic reducing system protects single cysteine residues from oxidationMatthieu Depuydt, Stephen E Leonard, Didier Vertommen, et al.The Lancet Regional Health. Europe|May 8, 2026
Time to diagnosis and treatment of obstructive sleep apnoea using mandibular jaw movement monitoring versus polysomnography: an open-label, multicentre, randomised, controlled trialJean-Louis Pépin, Renaud Tamisier, Marc Manceau, et al.Pageof 2